Sign in

CIK 0001802768

  • Large accelerated filer

Royalty Pharma plc

Sign in to watch
Ticker
RPRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
Operating
Phone
+1 212-883-0200
Business address
110 EAST 59TH STREET, NEW YORK, NY, 10022
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,327,503
in 3 filings, $6.3M under 10b5-1 plans

Net −$6,327,503. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-05 Engelbert Catherine M. Director Grant or award +4,545 55,673
2025-05-13 Engelbert Catherine M. Director Grant or award +7,614 51,128
2024-06-07 Engelbert Catherine M. Director Grant or award +9,293 43,514
2023-06-23 Engelbert Catherine M. Director Grant or award +7,747 33,211

Page 1 of 1 · 4 trades